<!DOCTYPE html>
<html lang="en">
<head>
<meta charset="utf-8">
<meta name="viewport" content="width=device-width,initial-scale=1">
<title>LC-MS metabolic profiling (HILIC-LC-QQQ-MS) distinguishes Colorectal Cancer — pCite</title>
<link rel="stylesheet" href="../css/style.css">
</head>
<body>
<header>
  <h1><a href="../index.html">pCite</a></h1>
  <nav><a href="../index.html">Search</a><a href="../corpus.html">Corpus</a></nav>
</header>

<p class="section-label">CLAIM</p>
<hr class="section-rule">
<div class="triple">
  <strong>LC-MS metabolic profiling (HILIC-LC-QQQ-MS)</strong>
  <span class="pred">&mdash;distinguishes&rarr;</span>
  <strong>Colorectal Cancer</strong>
</div>
<div class="entity-id">UNKNOWN:lc-ms metabolic profiling (hilic-lc-qqq-ms) &nbsp;&middot;&nbsp; MESH:D015179</div>

<p class="section-label">VALIDATION</p>
<hr class="section-rule">
<div class="val-bar" style="--pct:5%;--color:#f0a030"></div>
<div class="stat-row">
  <span>Class: Curated (0.5)</span>
  <span>Replicated: 1 paper</span>
  <span>Score: 15.99<span class="score-tip"><span class="tip-icon">&nbsp;&#9432;</span><span class="tip-text">Score = &Sigma; incoming citation weights. Each citation is weighted by the validation class of the source claim (Physical 10.0 &middot; Curated 0.5 &middot; AI 0.01) multiplied by the citation type (Replicates 1.5 &middot; Supports 1.0 &middot; Contradicts 0.8). A score of 364 means this claim received strong physical-tier citation support.</span></span></span>
</div>

<p class="section-label">SCORE BREAKDOWN</p>
<hr class="section-rule">
<div class="score-breakdown">Base weight: 0.50 (Curated, 1 paper)<br>Score from 11 citations: <strong>15.99</strong><br><span style="color:#888">4&times; extends (+2.75) &middot; 6&times; supports (+12.94) &middot; 1&times; applies (+0.30)</span></div>


<p class="section-label">EVIDENCE CHAIN &middot; 1 source</p>
<hr class="section-rule">
<div class="evidence-row"><span class="evidence-dot" style="background:#f0a030" title="Curated"></span><span>Curated</span><a href="https://doi.org/10.1007/978-1-4939-7765-9_15">10.1007/978-1-4939-7765-9_15</a></div>


<p class="section-label">CITATIONS RECEIVED &middot; 11 total</p>
<hr class="section-rule">
<div class="cite-bar"><span style="width:70px;text-align:right">Replicates</span><span class="cite-bar-fill" style="width:0px"></span><span>0</span></div>
<div class="cite-bar"><span style="width:70px;text-align:right">Supports</span><span class="cite-bar-fill" style="width:100px"></span><span>6</span><span class="cite-subtotal">&middot; +12.94</span></div>
<div class="cite-claim"><span class="evidence-dot" style="background:#ff7f0e"></span><span class="cite-claim-triple">ceramides — is_biomarker_for → colorectal adenocarcinoma tissue</span><span class="cite-claim-weight">+4.64</span><a href="../claim/fbddabef2bccbbf8.html">view &rarr;</a></div>
<div class="cite-claim"><span class="evidence-dot" style="background:#ff7f0e"></span><span class="cite-claim-triple">Fatty acids — is_biomarker_for → Colorectal Cancer</span><span class="cite-claim-weight">+6.00</span><a href="../claim/6ad1651b9e44eeed.html">view &rarr;</a></div>
<div class="cite-claim"><span class="evidence-dot" style="background:#f0a030"></span><span class="cite-claim-triple">Lysophosphatidylcholine (LysoPC) — is_biomarker_for → Colorectal Cancer</span><span class="cite-claim-weight">+0.79</span><a href="../claim/da12e4ff94bff4d9.html">view &rarr;</a></div>
<div class="cite-claim"><span class="evidence-dot" style="background:#f0a030"></span><span class="cite-claim-triple">Phosphatidylglycerol — is_biomarker_for → Colorectal Cancer</span><span class="cite-claim-weight">+0.50</span><a href="../claim/5ccf3ca6907853fc.html">view &rarr;</a></div>
<div class="cite-claim"><span class="evidence-dot" style="background:#f0a030"></span><span class="cite-claim-triple">Sterol esters — is_biomarker_for → Colorectal Cancer</span><span class="cite-claim-weight">+0.50</span><a href="../claim/2ddf49d0d1512692.html">view &rarr;</a></div>
<div class="cite-claim"><span class="evidence-dot" style="background:#f0a030"></span><span class="cite-claim-triple">Lipogenic phenotype (upregulated lipogenesis) — correlates_with → Colorectal Cancer tumor progression</span><span class="cite-claim-weight">+0.50</span><a href="../claim/fc1a0b488fe38bb6.html">view &rarr;</a></div>
<div class="cite-bar"><span style="width:70px;text-align:right">Contradicts</span><span class="cite-bar-fill" style="width:0px"></span><span>0</span></div>
<div class="cite-bar"><span style="width:70px;text-align:right">Extends</span><span class="cite-bar-fill" style="width:67px"></span><span>4</span><span class="cite-subtotal">&middot; +2.75</span></div>
<div class="cite-claim"><span class="evidence-dot" style="background:#f0a030"></span><span class="cite-claim-triple">phosphatidylcholine (PC 16:0/18:1) — distinguishes → pMMR vs dMMR colorectal cancer</span><span class="cite-claim-weight">+0.95</span><a href="../claim/7cd9963dbde9d220.html">view &rarr;</a></div>
<div class="cite-claim"><span class="evidence-dot" style="background:#f0a030"></span><span class="cite-claim-triple">PC(18:0/18:1) — distinguishes → Colorectal Cancer</span><span class="cite-claim-weight">+0.60</span><a href="../claim/8477d23a810774c9.html">view &rarr;</a></div>
<div class="cite-claim"><span class="evidence-dot" style="background:#f0a030"></span><span class="cite-claim-triple">PE(18:0/20:4) — distinguishes → Colorectal Cancer</span><span class="cite-claim-weight">+0.60</span><a href="../claim/bb50e0c283aa54f1.html">view &rarr;</a></div>
<div class="cite-claim"><span class="evidence-dot" style="background:#f0a030"></span><span class="cite-claim-triple">Phosphatidylethanolamine — increases → Colorectal Cancer tumor progression</span><span class="cite-claim-weight">+0.60</span><a href="../claim/367abe64d5d037b2.html">view &rarr;</a></div>
<div class="cite-bar"><span style="width:70px;text-align:right">Applies</span><span class="cite-bar-fill" style="width:17px"></span><span>1</span><span class="cite-subtotal">&middot; +0.30</span></div>
<div class="cite-claim"><span class="evidence-dot" style="background:#f0a030"></span><span class="cite-claim-triple">Phosphatidylcholine — increases → Colorectal Cancer tumor progression</span><span class="cite-claim-weight">+0.30</span><a href="../claim/bb313c103d3f8b81.html">view &rarr;</a></div>


<p class="section-label">IDENTIFIERS</p>
<hr class="section-rule">
<table class="id-table">
<tr><td>Claim ID</td><td><code>3469841a208c5dc1</code></td></tr>
<tr><td>Subject URI</td><td><a href="https://identifiers.org/UNKNOWN:lc-ms metabolic profiling (hilic-lc-qqq-ms)">UNKNOWN:lc-ms metabolic profiling (hilic-lc-qqq-ms)</a></td></tr>
<tr><td>Object URI</td><td><a href="https://identifiers.org/MESH:D015179">MESH:D015179</a></td></tr>
</table>
<footer>pCite — validation-weighted scientific claims</footer>
</body>
</html>
